ALDX•benzinga•April 3, 2025 at 12:05 PM

Aldeyra Therapeutics Receives Complete Response Letter From The U.S. FDA For The Reproxalap New Drug Application For The Treatment Of Signs And Symptoms Of Dry Eye Disease

No summary available.

Read the full article from the original source for complete details and context.

Article published on April 3, 2025 by benzinga